The Independent Voice of
European Private Equity

Advanced Search

Impilo becomes largest shareholder in Pelago Bioscience

Xhulio Ismalaj 17 August 2023

Nordic GP Impilo has completed an investment in Pelago Bioscience, making it the largest shareholder in the portfolio company.

Related Articles

Equistone sells Netherlands-based specialist manufacturer to Castik Capital

15/05/24

Mutares-backed Ganter Group strengthens German presence with add-on

15/05/24

Main Capital Partners exits Optimizers in trade sale

15/05/24

Genesis Capital to launch seventh private equity fund

15/05/24

Chiltern Capital promotes two, hires origination associate

15/05/24

Astorg VIII holds final close on €4.4bn

15/05/24